BLB&B Advisors decreased its stake in AmerisourceBergen Corp. (NYSE:ABC) by 0.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,045 shares of the company’s stock after selling 21 shares during the period. BLB&B Advisors’ holdings in AmerisourceBergen Corp. were worth $731,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. West Oak Capital boosted its stake in shares of AmerisourceBergen Corp. by 5.5% in the fourth quarter. West Oak Capital now owns 20,210 shares of the company’s stock valued at $2,095,979 after buying an additional 1,050 shares during the last quarter. Banced Corp boosted its stake in shares of AmerisourceBergen Corp. by 2.3% in the fourth quarter. Banced Corp now owns 5,468 shares of the company’s stock valued at $567,000 after buying an additional 122 shares during the last quarter. Reynolds Capital Management boosted its stake in shares of AmerisourceBergen Corp. by 21.4% in the fourth quarter. Reynolds Capital Management now owns 3,400 shares of the company’s stock valued at $353,000 after buying an additional 600 shares during the last quarter. ICON Advisers boosted its stake in shares of AmerisourceBergen Corp. by 61.6% in the third quarter. ICON Advisers now owns 69,500 shares of the company’s stock valued at $6,602,000 after buying an additional 26,500 shares during the last quarter. Finally, Atria Investments boosted its stake in shares of AmerisourceBergen Corp. by 29.6% in the fourth quarter. Atria Investments now owns 9,486 shares of the company’s stock valued at $929,000 after buying an additional 2,166 shares during the last quarter.

Shares of AmerisourceBergen Corp. (NYSE:ABC) opened at 91.26 on Wednesday. The stock’s 50 day moving average price is $98.96 and its 200-day moving average price is $100.44. AmerisourceBergen Corp. has a 52-week low of $89.68 and a 52-week high of $120.68. The firm’s market cap is $18.77 billion.

AmerisourceBergen Corp. (NYSE:ABC) last announced its quarterly earnings data on Thursday, October 29th. The company reported $1.17 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.01. The firm had revenue of $35.50 billion for the quarter, compared to the consensus estimate of $34.62 billion. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.10 earnings per share. On average, equities research analysts anticipate that AmerisourceBergen Corp. will post $5.83 earnings per share for the current fiscal year.

ABC has been the topic of several analyst reports. Morgan Stanley cut AmerisourceBergen Corp. from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $120.00 to $93.00 in a research note on Friday, October 2nd. Deutsche Bank reiterated a “hold” rating and issued a $106.00 price objective on shares of AmerisourceBergen Corp. in a research note on Monday, October 12th. Evercore ISI reiterated a “hold” rating on shares of AmerisourceBergen Corp. in a research note on Wednesday, October 7th. Cowen and Company restated a “hold” rating on shares of AmerisourceBergen Corp. in a research note on Tuesday, October 6th. Finally, Robert W. Baird restated a “neutral” rating and issued a $108.00 price target (down from $113.00) on shares of AmerisourceBergen Corp. in a research note on Tuesday, January 12th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $107.77.

In related news, EVP Dale Danilewitz sold 6,388 shares of the company’s stock in a transaction on Monday, November 16th. The shares were sold at an average price of $96.86, for a total transaction of $618,741.68. Following the completion of the sale, the executive vice president now directly owns 3,956 shares of the company’s stock, valued at approximately $383,178.16. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Richard C. Gozon sold 10,666 shares of the company’s stock in a transaction on Monday, November 23rd. The stock was sold at an average price of $99.00, for a total transaction of $1,055,934.00. Following the sale, the director now directly owns 47,776 shares of the company’s stock, valued at $4,729,824. The disclosure for this sale can be found here.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

12 Month Chart for NYSE:ABC

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for AmerisourceBergen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corp. and related companies with MarketBeat.com's FREE daily email newsletter.